Pfizer (CHIX:PFED) Asset Impairment Charge : €3,974 Mil (TTM As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Pfizer Asset Impairment Charge?

Pfizer's Asset Impairment Charge for the three months ended in Sep. 2024 was €585 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 was €3,974 Mil.

Pfizer Asset Impairment Charge Historical Data

The historical data trend for Pfizer's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Asset Impairment Charge Chart

Pfizer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

2,600.10

1,684.28

244.26

1,635.95

8,809.62

Pfizer Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Asset Impairment Charge	Get a 7-Day Free Trial															5,639.80	2,990.34	125.12	274.06	584.75

Pfizer Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €3,974 Mil.

Pfizer Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Pfizer's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (CHIX:PFEd) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEB:Germany PFE:Germany PFE:Germany PFE:Germany PFE:Germany PFE:Canada PFIZ34:Brazil PFE:Bulgaria PFE:Austria PFE:Argentina

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer Headlines

From GuruFocus

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 05-17-2010

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-15-2010

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 08-16-2010

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus • 08-14-2009

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus • 05-15-2009

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-16-2009